- Home
- BCSF vs THQ Comparison
BCSF vs THQ Comparison
Compare BCSF & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | BCSF | THQ |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 838.7M | 731.8M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCSF | THQ |
|---|---|---|
| Price | $12.20 | $18.58 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 386.0K | 194.1K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | ★ 14.61% | 7.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $240.80 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.82 | $15.14 |
| 52 Week High | $15.84 | $20.39 |
Technical Indicators
Market Signals| Indicator | BCSF | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 37.21 | 52.76 |
| Support Level | $11.92 | $17.60 |
| Resistance Level | $13.74 | $19.01 |
| Average True Range (ATR) | 0.30 | 0.38 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 27.79 | 60.00 |
Price Performance
Historical ComparisonAbout BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.